Articles by Hannah Kamenetsky

NIH advisory committee plans to explore alternative vectors for gene therapy

Americans understand the connection but think science education needs improvement

New USDA pharming-test rules leave biotechs unfazed, food-protection groups unsatisfied.

Presidential advisers plan new reports on stem cells and enhancements to bodies and minds.

Companies gather to learn about opportunities for public-private partnerships.

Experts question FDA authority over human cloning.

President's advisors defend and explain positions on cloning ban

US environment agency considers ethics and utility of toxics tests on human volunteers.

mouse hybrid plan faces patent challenge from activist Rifkin.